Business ❯ Healthcare ❯ Pharmaceuticals

Drug Manufacturing

Eli Lilly Novo Nordisk Revenue Forecast Production Expansion Pfizer Products Cost Reduction Generic Medicines Weight-Loss Medications Radioligand Therapies Production Facilities Acquisitions ADC Production Dr Reddy's Laboratories Pricing Strategies

Samsung Biologics to Buy GSK’s Human Genome Sciences Campus for $280 Million

Closing is targeted for late Q1 2026 with more than 500 Rockville employees set to remain.

Novartis Opens Carlsbad Radioligand Therapy Plant as U.S. Buildout Accelerates

Eli Lilly Unveils $3 Billion Netherlands Plant to Scale Production of Oral Weight‑Loss Pill

Novo Nordisk Freezes Hiring as Layoffs Loom in GLP-1 Retrenchment